GAL4 Reporter, BioAssay™ Kit (Glucocorticoid Receptor Pathway) (Glucocorticoid Receptor, GR, Nuclear Receptor Subfamily 3 Group C Member 1, NR3C1, GAL4/UAS)

Cat# 298409-500T

Size : 500Tests

Brand : US Biological

Request more information



298409 GAL4 Reporter, BioAssay™ Kit (Glucocorticoid Receptor Pathway) (Glucocorticoid Receptor, GR, Nuclear Receptor Subfamily 3 Group C Member 1, NR3C1, GAL4/UAS)

Clone Type
Polyclonal
Shipping Temp
Blue Ice
Storage Temp
4°C/-20°C

The glucocorticoid signaling pathway plays an important role in development, fluid homeostasis, cognition, immune response and metabolism. Glucocorticoids are a class of steroid hormones that bind to the glucocorticoid receptor, causing it to translocate to the nucleus. Upon translocation, the receptor can regulate the transcription of a large number of genes, including those that regulate glucose metabolism and inflammatory responses.||Sample Type:|Cultured cells||Intended Use:|Applications include monitoring glucocorticoid signaling pathway activity and for screening activators or inhibitors of the glucocorticoid signaling pathway.||Test Principle:|The Glucocorticoid Receptor Pathway Reporter BioAssay™ Kit is designed for monitoring the activity of the glucocorticoid signaling pathway in cultured cells. The kit contains a transfection-ready expression vector for the glucocorticoid receptor ligand binding domain that is fused to the DNA binding domain (DBD) of GAL4 (GAL4 DBD-GR). This fusion construct activates firefly luciferase expression under the control of a multimerized GAL4 upstream activation sequence (UAS). This allows for specific detection of glucocorticoid-induced activation of the glucocorticoid receptor without the need for individual transcriptional targets and with low crossreactivity for other nuclear receptor pathways. The GAL4/UAS reporter is premixed with constitutively expressing Renilla (sea pansy) luciferase vector, which serves as an internal positive control for transfection efficiency. ||The kit also includes a non-inducible firefly luciferase vector premixed with constitutively expressing Renilla luciferase vector as a negative control. The non-inducible luciferase vector contains a firefly luciferase gene under the control of a minimal promoter, but without any additional response elements. The negative control is critical for determining pathway-specific effects and background luciferase activity.||Kit Components:|Reporter (Component A), GAL4/UAS luciferase reporter vector + constitutively expressing|Renilla luciferase vector, 1x500ul, (60ng DNA/ul)|Negative Control Reporter (Component B), Non-inducible luciferase vector + constitutively expressing Renilla luciferase vector, 1x500ul, (60ng DNA/ul)|GAL4 DBD-GR (Component C), Expression vector for ligand binding domain of the|glucocorticoid receptor + GAL4 DNA binding domain, 1x250ul, (100ng DNA/ul)|Negative Control Expression vector (Component D), Expression vector with GAL4 DNA binding domain only, 1x250ul (100ng DNA/ul)||These vectors are ready for transient transfection. They are NOT SUITABLE for transformation|and amplification in bacteria.||Storage and Stability:|Store powder at 4°C liquid at -20°C. Store other components at 4°C. Stable for at least 6 months For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
References
1. Paguio A, et al. (2010) Improved Dual-Luciferase Reporter Assays for Nuclear Receptors. Curr|Chem Genomics. 4: 43-49.